Quest Diagnostics
851 hedge funds and large institutions have $14.3B invested in Quest Diagnostics in 2022 Q1 according to their latest regulatory filings, with 85 funds opening new positions, 268 increasing their positions, 327 reducing their positions, and 129 closing their positions.
2.49% more ownership
Funds ownership: 85.62% → 88.1% (+2.5%)
0% less call options, than puts
Call options by funds: $101M | Put options by funds: $101M
6% less funds holding
Funds holding: 905 → 851 (-54)
18% less repeat investments, than reductions
Existing positions increased: 268 | Existing positions reduced: 327
21% less capital invested
Capital invested by funds: $18B → $14.3B (-$3.73B)
25% less funds holding in top 10
Funds holding in top 10: 8 → 6 (-2)
34% less first-time investments, than exits
New positions opened: 85 | Existing positions closed: 129
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$163M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
+$92.6M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$88.7M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$55.6M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$46.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FMI
Fiduciary Management Inc
Milwaukee,
Wisconsin
|
-$103M |
| 2 |
AssetMark Inc
Concord,
California
|
-$55.6M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$55.5M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$54.8M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$46.1M |
DGX Hedge Fund Activity: Q1 2022 in Review
851 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q1 2022, worth a combined $14.3B — down 21% from $18B a quarter earlier.
Sellers outnumbered buyers: 129 funds closed out of DGX and 85 opened new positions — a net loss of 44 holders — while 327 trimmed existing stakes and 268 added.
The largest buyer was BlackRock, adding an estimated $163M. The largest seller was Fiduciary Management Inc, cutting an estimated $103M.
- 851 institutional investors held Quest Diagnostics (DGX) as of Q1 2022, down from 905 in Q4 2021.
- Funds reported $14.3B of Quest Diagnostics stock for Q1 2022, down 21% quarter-over-quarter.
- 85 funds opened new Quest Diagnostics positions in Q1 2022 and 129 closed out, a net change of -44 holders.
- The largest Quest Diagnostics buyer in Q1 2022 was BlackRock, an estimated $163M added.
- The largest Quest Diagnostics seller in Q1 2022 was Fiduciary Management Inc, an estimated $103M sold.
Based on aggregated 13F filings for Q1 2022.